Novo CEO pressed by Senate to cut costs of obesity, diabetes prescription drugs CEO Lars Fruergaard Jørgensen advised lawmakers the corporate would contemplate new talks with insurers regarding the record selling prices of Wegovy and copyright if they pledge to maintain the medicines on their own formularies. Previously this summer https://arizona-hard-tea-carbs00762.blogdal.com/31077867/not-known-factual-statements-about-healthcare-news